πŸ‡ΊπŸ‡Έ FDA
Patent

US 11993655

Anti-PD-L1 antibody and use thereof

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 11993655 (Anti-PD-L1 antibody and use thereof) held by Oricell Therapeutics Co., Ltd. expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Oricell Therapeutics Co., Ltd.
Grant date
Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/545, A61K31/713, A61P